Todd R. Palmby

3.7k citations

19 papers · 1.6k indexed · h-index 18

Molecular Biology top 10%
Oncology top 5%
Pulmonary and Respiratory Medicine top 10%
Cell Biology top 5%
Cancer Research top 10%

Co-authors: Richard Pazdur Channing J. Der Julie Gavard Panomwat Amornphimoltham Rajeshwari Sridhara Yi Zheng Wenfu Tan Shenghui Tang
Topics: Protein Kinase Regulation and GTPase Signaling (4 papers)HER2/EGFR in Cancer Research (4 papers)Advanced Breast Cancer Therapies (3 papers)
Cited by: Oncology Cell Biology Molecular Biology
Journals: Journal of Biological Chemistry Nature Communications Molecular and Cellular Biology
Partner nations: United States France

In The Last Decade

Todd R. Palmby

19 papers receiving 1.6k citations

Peers

Countries citing papers authored by Todd R. Palmby

Since Specialization

Citations

This map shows the geographic impact of Todd R. Palmby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd R. Palmby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd R. Palmby more than expected).

Fields of papers citing papers by Todd R. Palmby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd R. Palmby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd R. Palmby. The network helps show where Todd R. Palmby may publish in the future.

Co-authorship network of co-authors of Todd R. Palmby

This figure shows the co-authorship network connecting the top 25 collaborators of Todd R. Palmby. A scholar is included among the top collaborators of Todd R. Palmby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd R. Palmby. Todd R. Palmby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Decoding kinase-adverse event associations for small molecule kinase inhibitors 2022 ·Nature Communications ·Xiajing Gong,Meng Hu,Jinzhong Liu,(unknown),James Xu,Amy S. McKee,Todd R. Palmby,R. Angelo de Claro,Liang Zhao	13
2	FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer 2018 ·Clinical Cancer Research ·Anand Shah,Erik Bloomquist,Shenghui Tang,Wentao Fu,Youwei Bi,Qi Liu,Jingyu Yu,Ping Zhao,Todd R. Palmby,Kirsten B. Goldberg,(unknown),Paresma Patel,(unknown),Amy Tilley,William F. Pierce,Amna Ibrahim,Gideon M. Blumenthal,Rajeshwari Sridhara,Julia A. Beaver,Richard Pazdur	88
3	U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer 2018 ·Clinical Cancer Research ·Harpreet Singh,Amanda J. Walker,Laleh Amiri‐Kordestani,Joyce Cheng,Shenghui Tang,(unknown),(unknown),Todd R. Palmby,Xianhua Cao,(unknown),Qi Liu,Jingyu Yu,William F. Pierce,Selena Daniels,Rajeshwari Sridhara,Amna Ibrahim,Paul G. Kluetz,Gideon M. Blumenthal,Julia A. Beaver,Richard Pazdur	75
4	FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing Chemotherapy 2017 ·The Oncologist ·Yang‐Min Ning,Daniel L. Suzman,V. Ellen Maher,Lijun Zhang,Shenghui Tang,Tiffany K. Ricks,Todd R. Palmby,Wentao Fu,Qi Liu,Kirsten B. Goldberg,Geoffrey Kim,Richard Pazdur	112
5	21st Century Cardio-Oncology 2016 ·JACC Basic to Translational Science ·Calvin C. Sheng,Laleh Amiri‐Kordestani,Todd R. Palmby,Thomas Force,Charles C. Hong,Joseph C. Wu,Kevin Croce,Geoffrey Kim,Javid J. Moslehi	33
6	FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer 2016 ·Clinical Cancer Research ·Amanda J. Walker,Suparna Wedam,Laleh Amiri‐Kordestani,Erik Bloomquist,(unknown),Rajeshwari Sridhara,Wei Chen,Todd R. Palmby,Jeanne Fourie Zirkelbach,Wentao Fu,Qi Liu,Amy Tilley,Geoffrey Kim,Paul G. Kluetz,Amy E. McKee,Richard Pazdur	104
7	PDZ-RhoGEF and LARG Are Essential for Embryonic Development and Provide a Link between Thrombin and LPA Receptors and Rho Activation 2013 ·Journal of Biological Chemistry ·Constantinos M. Mikelis,Todd R. Palmby,May Simaan,Wenling Li,Roman Szabo,Ruth J. Lyons,Daniel Martı́n,Hiroshi Yagi,Shigetomo Fukuhara,Hiroki Chikumi,Rebeca Galisteo,Yoh‐suke Mukouyama,Thomas Bugge,J. Silvio Gutkind	52
8	U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma 2013 ·Clinical Cancer Research ·Michael D. Axelson,Ke Liu,Xiaoping Jiang,Kun He,Jian Wang,Hong Zhao,(unknown),Todd R. Palmby,Zedong Dong,Anne‐Marie Russell,Sarah Pope Miksinski,Patricia Keegan,Richard Pazdur	140
9	Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary 2013 ·Clinical Cancer Research ·Paul G. Kluetz,William F. Pierce,V. Ellen Maher,Hui Zhang,Shenghui Tang,Pengfei Song,Qi Liu,Martin T. Haber,Eldon E. Leutzinger,Ali Al‐Hakim,Wei Chen,Todd R. Palmby,(unknown),Rajeshwari Sridhara,Amna Ibrahim,Robert Justice,Richard Pazdur	125
10	Abiraterone Acetate in Combination with Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer: U.S. Food and Drug Administration Drug Approval Summary 2013 ·Clinical Cancer Research ·Paul G. Kluetz,Yang‐Min Ning,V. Ellen Maher,Lijun Zhang,Shenghui Tang,Debasis Ghosh,Robeena Aziz,Todd R. Palmby,(unknown),Jeanne Fourie Zirkelbach,Nitin Mehrotra,Amy Tilley,Rajeshwari Sridhara,Amna Ibrahim,Robert Justice,Richard Pazdur	49
11	Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary 2013 ·Clinical Cancer Research ·Yang‐Min Ning,William F. Pierce,V. Ellen Maher,Stella Karuri,Shenghui Tang,Haw-Jyh Chiu,Todd R. Palmby,Jeanne Fourie Zirkelbach,Dhananjay Marathe,Nitin Mehrotra,Qi Liu,Debasis Ghosh,(unknown),John K. Leighton,Rajeshwari Sridhara,Amna Ibrahim,Robert Justice,Richard Pazdur	39
12	U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma 2013 ·Clinical Cancer Research ·Thomas M. Herndon,Albert Deisseroth,Edvardas Kaminskas,Robert C. Kane,Kallappa M. Koti,Mark D. Rothmann,Bahru Habtemariam,Julie Bullock,Jeffrey D. Bray,Jessica J. Hawes,Todd R. Palmby,(unknown),William M. Adams,(unknown),Janice Brown,Angelica Dorantes,Rajeshwari Sridhara,Ann T. Farrell,Richard Pazdur	198
13	Semaphorin 3E Initiates Antiangiogenic Signaling through Plexin D1 by Regulating Arf6 and R-Ras 2010 ·Molecular and Cellular Biology ·Atsuko Sakurai,Julie Gavard,(unknown),John R. Basile,Panomwat Amornphimoltham,Todd R. Palmby,Hiroshi Yagi,Fan Zhang,Paul A. Randazzo,Xuri Li,Roberto Weigert,J. Silvio Gutkind	131
14	An essential role for Rac1 in endothelial cell function and vascular development 2008 ·The FASEB Journal ·Wenfu Tan,Todd R. Palmby,Julie Gavard,Panomwat Amornphimoltham,Yi Zheng,(unknown)	185
15	Multiple PPPS/TP motifs act in a combinatorial fashion to transduce Wnt signaling through LRP6 2007 ·FEBS Letters ·Joshua H. Wolf,Todd R. Palmby,Julie Gavard,Bart O. Williams,J. Silvio Gutkind	28
16	Vav Transformation Requires Activation of Multiple GTPases and Regulation of Gene Expression 2004 ·Molecular Cancer Research ·Todd R. Palmby,Karon Abe,Antoine E. Karnoub,Channing J. Der	20
17	Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation 2004 ·Oncogene ·Anurag Singh,Antoine E. Karnoub,Todd R. Palmby,Ernst Lengyel,John Sondek,Channing J. Der	147
18	Critical Role of the Pleckstrin Homology and Cysteine-rich Domains in Vav Signaling and Transforming Activity 2002 ·Journal of Biological Chemistry ·Todd R. Palmby,Karon Abe,Channing J. Der	23
19	Cellular N-Ras Promotes Cell Survival by Downregulation of Jun N-Terminal Protein Kinase and p38 2002 ·Molecular and Cellular Biology ·(unknown),Todd R. Palmby,Channing J. Der,Alan Wolfman	59

About Todd R. Palmby

Todd R. Palmby is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (4 papers), HER2/EGFR in Cancer Research (4 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Oncology (541 citations), Cell Biology (225 citations) and Molecular Biology (927 citations). Todd R. Palmby has collaborated with scholars based in United States and France. Frequent co-authors include Richard Pazdur, Channing J. Der, Julie Gavard, Panomwat Amornphimoltham, Rajeshwari Sridhara, Yi Zheng, Wenfu Tan, Shenghui Tang, Antoine E. Karnoub and John Sondek. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact